AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Reyglim-M3 Tablet SR

Prescription Icon
Prescription Required

Marketer

Sanrey Therapeutics

Salt Composition

Glimepiride (3mg) + Metformin (500mg)

Overview Reyglim-M3 Tablet SR

Diabetic medication, Glycemia-Duo SR, combines two agents to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose. Glycemia-Duo SR should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial, even with controlled blood sugar; abrupt cessation increases the risk of complications, including kidney impairment, vision loss, neuropathy, and limb amputation. Remember, it's a component of a broader treatment plan encompassing diet, exercise, and weight management as guided by your healthcare provider. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms such as sweating, dizziness, headache, and tremors. Learn to recognize and manage these symptoms. Maintain regular mealtimes and carry readily-available glucose sources, like sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also possible. Glycemia-Duo SR is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal dysfunction. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.

Uses of Reyglim-M3 Tablet SR

Managing type 2 diabetes

Major Benefits of Reyglim-M3 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Reyglim-M3 Tablet SR whole; do not crush, chew, or break it. Administer this medication with a meal.

Common Side effects of Reyglim-M3 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Reyglim-M3 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Reyglim-M3 Tablet SR with a meal.

How Reyglim-M3 Tablet SR works:

Reyglim-M3 SR tablets contain a dual-action formulation of glimepiride and metformin, both effective in managing diabetes. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts through a three-pronged approach: decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Reyglim-M3 Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Reyglim-M3 SR tablets during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Reyglim-M3 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Reyglim-M3 Tablet SR cautiously, potentially requiring a modified dosage. Severe kidney disease contraindicates Reyglim-M3 Tablet SR use. Medical advice is necessary. Regular kidney function assessments are recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Reyglim-M3 Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, Reyglim-M3 Tablet SR is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Reyglim-M3 Tablet SR :

Should you forget a dose of Reyglim-M3 Tablet SR, take it immediately if you remember. Otherwise, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Reyglim-M3 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Reyglim-M3 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Reyglim-M3 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). While rare, this harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Reyglim-M3 Tablet SR and seek immediate medical attention.
Reyglim-M3 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood sugar control when used with a healthy diet and regular exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for treating type 1 DM.
Reyglim-M3 SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Yes, prolonged Reyglim-M3 Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and gait problems), urinary issues, cognitive changes, and balance difficulties. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Reyglim-M3 SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Reyglim-M3 SR tablets and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
Reyglim-M3 Tablet SR
92
MRP 112
17% off